Novel vaccine show promise for relapsing-remitting MS

Author：

ISSN： 1173-8324

Source： Inpharma, Vol.1, Iss.1657, 2008-01, pp. : 12-12

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

IFN- treatment cost driver in relapsing-remitting MS

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 458, 2004-01 ,pp. : 7-7

Adis International

Access to resources Recommend Favorite

IFN- treatment cost driver in relapsing-remitting MS

Inpharma, Vol. 1, Iss. 1448, 2004-01 ,pp. : 4-4

Adis International

Access to resources Recommend Favorite

Laquinimod beneficial in relapsing-remitting MS?

Inpharma, Vol. 1, Iss. 1645, 2008-01 ,pp. : 4-4

Adis International

Access to resources Recommend Favorite

Interferon- -1b good value for money in relapsing-remitting MS

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 317, 2001-01 ,pp. : 10-10

Adis International

Access to resources Recommend Favorite

Cladribine tablets for the treatment of relapsing–remitting multiple sclerosis

By Comi Giancarlo Hartung Hans-Peter Kurukulasuriya Nuwan C Greenberg Steven J Scaramozza Matthew

Expert Opinion on Pharmacotherapy, Vol. 14, Iss. 1, 2013-01 ,pp. : 123-136

Informa Healthcare

Access to resources Recommend Favorite